摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    532.2±50.0 °C(predicted)
  • 密度:
    1.356±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    60.4
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of cyclopentanthraquinones: analogs of mitomycin C
    摘要:
    2,3-Dihydro-1H-cyclopent[a]anthracene-6,11-dione (cyclopentanthraquinone) derivatives bearing a mustard side chain at C-4 and an aziridine ring at the cyclopentene moiety were synthesized. Such a compound may be viewed as an analogue of mitomycin C (MC) and may exhibit bifunctional DNA-alkylating and DNA-intercalating agent. The key intermediate, 4-hydroxy-2,3-di-O-substituted cyclopentanthraquinone, was synthesized by Deils-Alder reaction of naphthoquinone with various 4,5-dihydroxy-1-vinylcyclopent-1-ene derivatives. Introduction of a mustard side chain to the OH group at C-4 and subsequent construction of an aziridine-ring on C2-C3 of the cyclopentanthraquinone molecule furnished the target compound, 2,3-aziridino-4-[2-[NN-bis(2-chloroethyl)amino]ethoxy]-2,3-dihydro-1H-cyclopent [a] anthracene-6,11-dione (37). It was found that both the aziridine function and the mustard side chain play a significant role in their cytotoxicity against leukemic L1210 and HL-60 cell growth in culture and the inhibition of topoisomerase II kDNA decatenation.
    DOI:
    10.1021/jo00059a014
  • 作为产物:
    描述:
    1-Acetoxy-1-(cyclopent-1-enyl)ethene 在 palladium on activated charcoal 作用下, 以 甲苯 为溶剂, 生成 4-acetoxy-2,3-dihydro-1H-cyclopentanthracene-6,11-dione
    参考文献:
    名称:
    Synthesis of cyclopentanthraquinones: analogs of mitomycin C
    摘要:
    2,3-Dihydro-1H-cyclopent[a]anthracene-6,11-dione (cyclopentanthraquinone) derivatives bearing a mustard side chain at C-4 and an aziridine ring at the cyclopentene moiety were synthesized. Such a compound may be viewed as an analogue of mitomycin C (MC) and may exhibit bifunctional DNA-alkylating and DNA-intercalating agent. The key intermediate, 4-hydroxy-2,3-di-O-substituted cyclopentanthraquinone, was synthesized by Deils-Alder reaction of naphthoquinone with various 4,5-dihydroxy-1-vinylcyclopent-1-ene derivatives. Introduction of a mustard side chain to the OH group at C-4 and subsequent construction of an aziridine-ring on C2-C3 of the cyclopentanthraquinone molecule furnished the target compound, 2,3-aziridino-4-[2-[NN-bis(2-chloroethyl)amino]ethoxy]-2,3-dihydro-1H-cyclopent [a] anthracene-6,11-dione (37). It was found that both the aziridine function and the mustard side chain play a significant role in their cytotoxicity against leukemic L1210 and HL-60 cell growth in culture and the inhibition of topoisomerase II kDNA decatenation.
    DOI:
    10.1021/jo00059a014
点击查看最新优质反应信息

文献信息

  • Antitumor cyclopentnaphthoquinone and cyclopentanthraquinone derivatives
    申请人:Sloan-Kettering Institute for Cancer Research
    公开号:US05476952A1
    公开(公告)日:1995-12-19
    The present invention provides compounds having the structure: ##STR1## or having the structure: ##STR2## The present invention also provides a pharmaceutical compostion containing the compounds, methods of synthesizing the compounds, as well as methods of inhibiting growth of tumor cells and of treating a subject having a disease characterized by the proliferation of tumor cells.
    本发明提供具有以下结构的化合物:##STR1## 或具有以下结构的化合物:##STR2## 本发明还提供含有这些化合物的药物组合物,合成这些化合物的方法,以及抑制肿瘤细胞生长和治疗患有肿瘤细胞增殖性疾病的受试者的方法。
  • US5476952A
    申请人:——
    公开号:US5476952A
    公开(公告)日:1995-12-19
  • [EN] ANTITUMOR CYCLOPENTANPHTHOQUINONE AND CYCLOPENTANTHRAQUINONE DERIVATIVES<br/>[FR] DERIVES DE CYCLOPENTANAPHTOQUINONE ET DE CYCLOPENTANTHRAQUINONE A ACTION ANTITUMORALE
    申请人:SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
    公开号:WO1994020094A1
    公开(公告)日:1994-09-15
    (EN) The present invention provides compounds having structure (I) or having structure (II). The present invention also provides a pharmaceutical composition containing the compounds, methods of synthesizing the compounds, as well as methods of inhibiting growth of tumor cells and of treating a subject having a disease characterized by the proliferation of tumor cells.(FR) L'invention se rapporte à des composés ayant la structure (I) ou la structure (II). L'invention décrit également une composition pharmaceutique contenant ces composés, des procédés de synthèse de ces composés, ainsi que des procédés pour inhiber la croissance de cellules tumorales et pour traiter un sujet atteint d'une maladie se caractérisant par une prolifération de cellules tumorales.
查看更多

同类化合物

齐斯托醌 黄决明素 马普替林相关物质D 马普替林杂质E(N-甲基马普替林) 马普替林杂质D 马普替林D3 马普替林 颜料黄199 颜料黄147 颜料黄123 颜料黄108 颜料红89 颜料红85 颜料红251 颜料红177 颜料紫27 顺式-1-(9-蒽基)-2-硝基乙烯 阿美蒽醌 阳离子蓝FGL 阳离子蓝3RL 长蠕孢素 镁蒽四氢呋喃络合物 镁蒽 锈色洋地黄醌醇 锂钠2-[[4-[[3-[(4-氨基-9,10-二氧代-3-磺基-1-蒽基)氨基]-2,2-二甲基-丙基]氨基]-6-氯-1,3,5-三嗪-2-基]氨基]苯-1,4-二磺酸酯 锂胭脂红 链蠕孢素 铷离子载体I 铝洋红 铂(2+)二氯化1-({2-[(2-氨基乙基)氨基]乙基}氨基)蒽-9,10-二酮(1:1) 钾6,11-二氧代-6,11-二氢-1H-蒽并[1,2-d][1,2,3]三唑-4-磺酸酯 钠alpha-(丙烯酰氨基)-[4-[[9,10-二氢-4-(异丙基氨基)-9,10-二氧代-1-蒽基]氨基]苯氧基]甲苯磺酸盐 钠[[3-[[4-(环己基氨基)-9,10-二氢-9,10-二氧代-1-蒽基]氨基]-1-氧代丙基]氨基]苯磺酸盐 钠[3-[[9,10-二氢-4-(异丙基氨基)-9,10-二氧代-1-蒽基]氨基]丁基]苯磺酸盐 钠6,11-二氧代-6,11-二氢-1H-蒽并[1,2-d][1,2,3]三唑-4-磺酸酯 钠4-({4-[乙酰基(乙基)氨基]苯基}氨基)-1-氨基-9,10-二氧代-9,10-二氢-2-蒽磺酸酯 钠2-[(4-氨基-9,10-二氧代-3-磺基-9,10-二氢-1-蒽基)氨基]-4-{[2-(磺基氧基)乙基]磺酰基}苯甲酸酯 钠1-氨基-9,10-二氢-4-[[4-(1,1-二甲基乙基)-2-甲基苯基]氨基]-9,10-二氧代蒽-2-磺酸盐 钠1-氨基-4-[(3-{[(4-甲基苯基)磺酰基]氨基}苯基)氨基]-9,10-二氧代-9,10-二氢-2-蒽磺酸酯 钠1-氨基-4-[(3,4-二甲基苯基)氨基]-9,10-二氧代-9,10-二氢-2-蒽磺酸酯 钠1-氨基-4-(1,3-苯并噻唑-2-基硫基)-9,10-二氧代蒽-2-磺酸盐 醌茜隐色体 醌茜素 酸性蓝P-RLS 酸性蓝41 酸性蓝27 酸性蓝127:1 酸性紫48 酸性紫43 酸性兰62